Benign Prostatic Hyperplasia Market By Treatment Type (Pharmacological Treatment {Alpha Blockers, 5-alpha-reductase Inhibitors, Combination Therapy, Phytotherapy}, Minimally Invasive Procedures {UroLift System, Rezūm Therapy, Prostatic Artery Embolization}, Surgical Treatment {Transurethral Resection of the Prostate, Laser Surgery, Open Prostatectomy}), By Dosage Form (Oral Immediate-Release, Oral Extended-Release, Others), By Diagnostic Method (Digital Rectal Exam, Prostate-Specific Antigen Test, Ultrasound, Urinary Flow Study, Cystoscopy), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Homecare, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Jul 2025 | Report ID: MI3037 | 218 Pages

Report Summary Table of Contents Segmentation FAQ Request Sample Report

Report Coverage:

By Treatment Type

Pharmacological Treatment
- Alpha Blockers
- 5-alpha-reductase Inhibitors
- Combination Therapy
- Phytotherapy
Minimally Invasive Procedures
- UroLift System
- Rezūm Therapy
- Prostatic Artery Embolization
Surgical Treatment
- Transurethral Resection of the Prostate
- Laser Surgery
- Open Prostatectomy